Lethal Weapon Star Danny Glover Reveals Alzheimer’s Diagnosis

<>

Danny Glover, 79, disclosed during an interview on The Today Show that he has been living with Alzheimer’s disease for several years. The actor, best known for his role in the Lethal Weapon film series, confirmed the diagnosis occurred “not long” after he received an honorary Oscar in 2022. “I could live with it, in a sense. I’m sure as it advances, things are going to be different and changing,” Glover said, noting that his movements, speech, and memory have slowed. His comments were shared in a statement provided by his representatives.

Glover described the progression of the disease as “a process,” emphasizing that his family’s support has been critical. “Your life continues,” he said, adding, “I don’t feel like it’s the end of my life. There’s work to do.” The actor did not specify the exact timeline of his diagnosis but linked it to the period following his 2022 honorary Oscar, which was presented at the Academy Awards ceremony.

Alzheimer’s disease, the most common cause of dementia, affects memory, thinking, and behavior. According to the Alzheimer’s Association, millions of Americans are living with the condition, and symptoms typically progress over time. Early signs often include difficulty remembering recent events, while later stages may involve challenges with daily tasks and communication. The disease is currently incurable, though treatments can help manage symptoms.

Glover’s public acknowledgment of his diagnosis aligns with a growing trend of celebrities and public figures sharing their experiences with neurodegenerative diseases. In 2021, actor Michael J. Fox, who has Parkinson’s disease, spoke about the importance of advocacy and research funding. Similarly, former U.S. President Ronald Reagan’s public battle with Alzheimer’s in the 1990s helped raise awareness about the condition.

The actor’s remarks come as research into Alzheimer’s continues to evolve. A 2023 study published in Nature Medicine highlighted the potential of early detection methods using blood tests to identify biomarkers associated with the disease. However, no cure has been developed, and treatment remains focused on slowing progression. The Alzheimer’s Association estimates that the disease costs the U.S. healthcare system hundreds of billions of dollars annually, with caregiving responsibilities often falling to family members.

Glover’s representatives did not provide additional details about his current health status or treatment